Loading clinical trials...
Loading clinical trials...
Patient and Provider Confidence and Satisfaction With the Clinical Use of CYP Genetic Variability Analysis to Guide Analgesic Treatment: A Randomized, Controlled Pilot Study Using the Pain Medication and Mental Health DNA InsightTM Test.
Conditions
Interventions
Pain Medication DNA Insight (TM) test
Locations
1
United States
Womack Army Medical Center
Fort Bragg, North Carolina, United States
Start Date
July 1, 2015
Primary Completion Date
October 1, 2017
Completion Date
December 1, 2017
Last Updated
August 15, 2023
NCT06346132
NCT07351968
NCT07482709
NCT06946290
NCT07041736
NCT06528288
Lead Sponsor
Defense and Veterans Center for Integrative Pain Management
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions